Commit To Purchase Monte Rosa Therapeutics At $2.50, Earn 18.5% Annualized Using Options

Investors eyeing a purchase of Monte Rosa Therapeutics Inc (GLUE) stock, but cautious about paying the going market price of $4.04/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2025 put at the $2.50 strike, which has a bid at the time of this writing of 20 cents..